Ubrelvy is an oral medication approved in the United States for acute treatment of migraine, which means that you take it to treat an attack when you notice symptoms. It’s one of several new ...

The Food and Drug Administration (FDA) has expanded the approval of Nerivio ® (Theranica) to include the acute and/or ...

According to the medical journal Neurology, researchers said those who took ubrogepant or Ubrelvy were ... on our findings, treatment with ubrogepant may allow people with migraine who experience ...

Monthly 140 mg erenumab injections are a safe and effective treatment for patients with nonopioid chronic migraine and medication overuse headaches.

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...

The key to stopping a migraine episode is early recognition and treatment. Treatments are more likely to be successful when you start them early rather than waiting to see if the symptoms get worse.

especially when traditional oral migraine medications can take half an hour to an hour, or even more, to work. Tonix, known for its work in developing new treatments for central nervous system (CNS) ...

Emgality (galcanezumab-gnlm) is prescribed for migraine prevention and to treat cluster headaches. Emgality may cause mild side effects and serious side effects. Like all medications, Emgality can ...

One class of drugs has already found success in treating the painful, disorienting and common attacks. Excitement is building about a slew of additional drug targets.

5-hydroxytriptamine is a key mediator in the pathogenesis of migraine and thus 5-HT 1-receptor agonists are the principal drugs for acute migraine therapy. There are three classes of drugs for ...

Now, she’s on disability due to her migraine. Irons has tried so many migraine medications she’s lost count — but none has helped for long. Even a few of the much-touted new drugs that have ...

Pain-sensing neurons exchange signals with immune cells that drive endometriosis, sparking the pain associated with the condition, new research suggests.